Supply Chain

Eclipse is able to support regional and national supply chain for safe and effective clinical support programmes

Our Team already support national logistics for NHS Procurement and are working with the NHS national supply team (National Clinical Directors and to ensure improved supply.

Medicines management teams can benefit from live indicative stock updates and medicines optimisation programmes to save £500million per year in cost and 500 million tonnes of Carbon offset (Impact500)

Supply Chain Projects

  • IMPACT500 Medicines Optimisations

  • National Logistics for NHS Procurement

  • Carbon Optimisation Programmes

The NHS has been under considerable pressure over the past year in relation to the COVID-19 pandemic.

the ECLIPSE solution launched to support patients, practices and NHS commissioners to deliver safer, cost-effective and impactful prescribing pathways.

ECLIPSE allows for sustainable prescribing through:

  1. Identification of prescriptions related with improved outcomes for patients.

  2. Supporting medicines manufactured by companies committed to the NHS Green Agenda.

  3. Saving £500 million a year through cost-effective prescribing.

  4. Reducing carbon emissions by 500 thousand tonnes/year.

The most sustainable and effective way to reduce the carbon footprint of the NHS is to embed patient safety into its core function - keep patients well and out of hospital.

By ensuring patients are on the right medicines with the right monitoring and are effectively supported, this programme will save over £500 million for the NHS and reduce carbon emissions by 500 thousand tonnes a year. the service ensures the appropriate use of clinical data, smart analytics and NHS patient support programmes to deliver improved compliance, monitoring and outcomes for patients with a significant impact on the NHS carbon footprint.

ECLIPSE Supply Chain Delivery

In Summary

Aiming to deliver £500 million of savings for our NHS this year and reduce the carbon impact of the NHS by 500 thousand tonnes p/a.

Identify products that will qualify for the programme. This qualification is independently validated by an external governance body (National Medicines Optimisation Group).

We have a standardised monthly fee per product line to enable membership of the programme with no risk (full refund if cancelled within the first three months).

These funds are used to support prescribing Carbon offset programmes for the NHS. All GP surgeries, Primary Care Networks, CCGs / ICSs will have free access to this service.

There is absolute compliance with best practice guidelines for NHS engagement. All optimisations are locally selected and secondarily validated by the regional NHS organisations.

Together we can ensure that cost-effective brands are appropriately used, our patients remain safe and both the NHS and the planet realise significant carbon offset.